Virtual Library
Start Your Search
Leah Fine
Author of
-
+
MA19 - Looking at PROs in Greater Detail - What Patients Actually Want and Expect (ID 147)
- Event: WCLC 2019
- Type: Mini Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Presentations: 1
- Now Available
- Moderators:Joaquim Bosch-Barrera, Virginia Calvo De Juan
- Coordinates: 9/10/2019, 11:30 - 13:00, Interlaken (1988)
-
+
MA19.05 - Improving Lung Cancer Outcomes and Quality in the US Community Setting with the Creation of Lung Cancer Centers of Excellence Program (Now Available) (ID 1939)
11:30 - 13:00 | Author(s): Leah Fine
- Abstract
- Presentation
Background
The Addario Lung Cancer Foundation community hospital Centers of Excellence (COE) Program encourages community cancer centers in the US to implement ‘best practices’ across the lung cancer care continuum, including provision of coordinated, multidisciplinary care. By comparing performance metrics within and outside the network of COEs, the program seeks to ensure that lung cancer patients (pts) receive the highest quality of care in their local area whilst also enabling COE hospitals to gain insights that facilitate the rapid implementation of quality improvement cycles.
Method
The Impact Study was launched to conduct a comprehensive comparative analysis of COE member and non-member institutions across numerous quantitative and qualitative metrics from within the lung cancer care continuum. The 2018 analysis included 17 COE sites and 19 non-COE community hospitals representing approximately 5,000 pts in each cohort. The COE Impact study captured pts’ demographic and clinical information as well as performance metrics from early stage screening through late stage diagnosis and all aspects of pts’ care.
Result
ConclusionVariable
COE
Non-COE
P value
# Cancer centers/hospitals
17
19
Answers collected by nurse navigator
41%
100%
<0.001
Average # of hospital beds
565
342
0.104
Average # of lung cancer pts/institution
497
470
0.968
Lung cancer screening program
94%
42%
0.001
Endoscopic Bronchoscopy Ultrasound (EBUS)
23%
16%
0.323
Screening of pts for clinical trials
81%
35%
<0.001
Race: Caucasians
81%
37%
<0.001
Pathologist in tumor boards
100%
67%
0.012
ER visits the first 4 months of therapy
14%
32%
0.022
Molecular testing of pts with metastatic disease
81%
48%
0.001
Next generation sequencing
58%
22%
0.009
Improved structure and processes of care delivery at COE hospitals may translate into improved quality of care, outcomes, and patient experiences. The Lung Cancer COE program, now including 38 community cancer centers encompassing 12,000 lung cancer patients, plans to conduct this study annually with prospective, longitudinal data collection for future trend analyses as a means of facilitating continuous quality improvement in community-level lung cancer care.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.